Corton Capital Inc. Avidity Biosciences, Inc. Transaction History

Corton Capital Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$9.16 - $25.52 $43,510 - $121,220	-4,750 Reduced 15.99%	24,954 $636,000
Q4 2023 Feb 14, 2024	BUY	$4.87 - $9.37 $22,664 - $43,607	4,654 Added 18.58%	29,704 $268,000
Q3 2023 Nov 14, 2023	BUY	$6.3 - $11.35 $79,972 - $144,076	12,694 Added 102.74%	25,050 $159,000
Q2 2023 Aug 14, 2023	BUY	$10.62 - $17.34 $131,220 - $214,253	12,356 New	12,356 $137,000

251

107M

224K

161K

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $1.82B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

Get notified when there are updates to the investment portfolio of Corton Capital Inc., based on Form 13F filings with the SEC.

Stay updated on Corton Capital Inc. with notifications on news.